tiprankstipranks
Trending News
More News >
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Financial Statements

Compare
399 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently $3.38B. The company's EPS TTM is $1.24; its P/E ratio is 21.24; Haemonetics is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $1.01. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 1.36B$ 1.31B$ 1.17B$ 993.20M$ 870.46M
Gross Profit$ 748.96M$ 691.55M$ 615.10M$ 505.50M$ 397.84M
Operating Income$ 221.82M$ 164.88M$ 156.03M$ 80.75M$ 57.96M
EBITDA$ 221.82M$ 265.58M$ 249.34M$ 178.50M$ 142.25M
Net Income$ 167.68M$ 117.56M$ 115.40M$ 43.38M$ 79.47M
Balance Sheet
Cash & Short-Term Investments$ 306.76M$ 178.80M$ 284.47M$ 259.50M$ 192.31M
Total Assets$ 2.45B$ 2.20B$ 1.93B$ 1.86B$ 1.82B
Total Debt$ 303.56M$ 807.79M$ 765.89M$ 773.59M$ 707.61M
Net Debt$ -3.21M$ 628.99M$ 481.42M$ 514.09M$ 515.30M
Total Liabilities$ 1.63B$ 1.24B$ 1.12B$ 1.11B$ 1.09B
Stockholders' Equity$ 820.84M$ 959.96M$ 818.00M$ 749.42M$ 731.67M
Cash Flow
Free Cash Flow$ 142.45M$ 115.45M$ 162.87M$ 75.75M$ 71.77M
Operating Cash Flow$ 181.72M$ 181.75M$ 273.06M$ 172.26M$ 108.81M
Investing Cash Flow$ -161.90M$ -322.39M$ -143.79M$ -86.34M$ -425.44M
Financing Cash Flow$ 108.82M$ 38.16M$ -100.36M$ -15.75M$ 367.45M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis